Sera Prognostics, Inc.

NasdaqGM SERA

Sera Prognostics, Inc. Inventory for the quarter ending September 30, 2024

Sera Prognostics, Inc. Inventory is NA for the quarter ending September 30, 2024. Inventory is the value of goods held by a company for sale or used in the production process.

Sera Prognostics, Inc. Inventory for the quarter ending September 30, 2023 was USD 1.00, a 0.00% change year over year.
Sera Prognostics, Inc. Inventory for the quarter ending September 30, 2022 was USD 1.00, a 0.00% change year over year.
Sera Prognostics, Inc. Inventory for the quarter ending September 30, 2021 was USD 0.00.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

NasdaqGM: SERA

Sera Prognostics, Inc.

CEO	Ms. Evguenia Lindgardt M.B.A.
IPO Date	July 15, 2021
Location	United States
Headquarters	2749 East Parleys Way
Employees	55
Sector	Healthcare
Industries Biotechnology 3D Printing Baby & Childcare Clinical Trials Cosmetics Personal Care Pharmaceuticals Vaccines

Description

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.

Key trends

Past 5 years